These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 30275490)

  • 41. Molecular heterogeneity of diffuse large B-cell lymphoma: implications for disease management and prognosis.
    Rossi D; Gaidano G
    Hematology; 2002 Aug; 7(4):239-52. PubMed ID: 14972786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular impact of selective NFKB1 and NFKB2 signaling on DLBCL phenotype.
    Guo X; Koff JL; Moffitt AB; Cinar M; Ramachandiran S; Chen Z; Switchenko JM; Mosunjac M; Neill SG; Mann KP; Bagirov M; Du Y; Natkunam Y; Khoury HJ; Rossi MR; Harris W; Flowers CR; Lossos IS; Boise LH; Dave SS; Kowalski J; Bernal-Mizrachi L
    Oncogene; 2017 Jul; 36(29):4224-4232. PubMed ID: 28368397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinicopathologic implication of microRNA-197 in diffuse large B cell lymphoma.
    Yang JM; Jang JY; Jeon YK; Paik JH
    J Transl Med; 2018 Jun; 16(1):162. PubMed ID: 29890998
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fas and Fas ligand expression on germinal center type-diffuse large B-cell lymphoma is associated with the clinical outcome.
    Kojima Y; Tsurumi H; Goto N; Shimizu M; Kasahara S; Yamada T; Kanemura N; Hara T; Sawada M; Saio M; Yamada T; Takahashi T; Tomita E; Takami T; Moriwaki H
    Eur J Haematol; 2006 Jun; 76(6):465-72. PubMed ID: 16494623
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Mechanism and clinical significance of anti-apoptotic gene bcl-2 expression in diffuse large B-cell lymphoma].
    Zeng LP; Wen YL; Ma Y; Wang GQ; Li Y; Wang J; Xu LL; Zhang XM
    Zhonghua Bing Li Xue Za Zhi; 2011 Jun; 40(6):377-81. PubMed ID: 21914345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of nuclear factor-κB regulators TNFAIP3 and CARD11 in Middle Eastern diffuse large B-cell lymphoma.
    Bu R; Bavi P; Abubaker J; Jehan Z; Al-Haqawi W; Ajarim D; Al-Dayel F; Uddin S; Al-Kuraya KS
    Leuk Lymphoma; 2012 Oct; 53(10):1971-7. PubMed ID: 22397314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Somatic mutations of cell-free circulating DNA detected by next-generation sequencing reflect the genetic changes in both germinal center B-cell-like and activated B-cell-like diffuse large B-cell lymphomas at the time of diagnosis.
    Bohers E; Viailly PJ; Dubois S; Bertrand P; Maingonnat C; Mareschal S; Ruminy P; Picquenot JM; Bastard C; Desmots F; Fest T; Leroy K; Tilly H; Jardin F
    Haematologica; 2015 Jul; 100(7):e280-4. PubMed ID: 25749829
    [No Abstract]   [Full Text] [Related]  

  • 48. FOXP2-positive diffuse large B-cell lymphomas exhibit a poor response to R-CHOP therapy and distinct biological signatures.
    Wong KK; Gascoyne DM; Soilleux EJ; Lyne L; Spearman H; Roncador G; Pedersen LM; Møller MB; Green TM; Banham AH
    Oncotarget; 2016 Aug; 7(33):52940-52956. PubMed ID: 27224915
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphoma.
    Fu K; Weisenburger DD; Choi WW; Perry KD; Smith LM; Shi X; Hans CP; Greiner TC; Bierman PJ; Bociek RG; Armitage JO; Chan WC; Vose JM
    J Clin Oncol; 2008 Oct; 26(28):4587-94. PubMed ID: 18662967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. DNMT1 is associated with cell cycle and DNA replication gene sets in diffuse large B-cell lymphoma.
    Loo SK; Ab Hamid SS; Musa M; Wong KK
    Pathol Res Pract; 2018 Jan; 214(1):134-143. PubMed ID: 29137822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular genetics of aggressive B-cell lymphoma.
    Dalla-Favera R
    Hematol Oncol; 2017 Jun; 35 Suppl 1():76-79. PubMed ID: 28591417
    [No Abstract]   [Full Text] [Related]  

  • 52. Genetic inactivation of TRAF3 in canine and human B-cell lymphoma.
    Bushell KR; Kim Y; Chan FC; Ben-Neriah S; Jenks A; Alcaide M; Fornika D; Grande BM; Arthur S; Gascoyne RD; Steidl C; Morin RD
    Blood; 2015 Feb; 125(6):999-1005. PubMed ID: 25468570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas.
    van Galen JC; Muris JJ; Giroth CP; Vos W; Ossenkoppele GJ; Meijer CJ; Oudejans JJ
    Histopathology; 2008 Apr; 52(5):578-84. PubMed ID: 18312353
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Immunophenotypes and prognosis of diffuse large B-cell lymphoma: a study of 500 cases].
    Luo DL; Liu YH; Zhuang HG; Li L; Xu FP; Zhang F; Luo XL; Xu J
    Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):235-9. PubMed ID: 21615996
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overexpression of heme oxygenase-1 induced by constitutively activated NF-κB as a potential therapeutic target for activated B-cell-like diffuse large B-cell lymphoma.
    Huang J; Guo P; Ma D; Lin X; Fang Q; Wang J
    Int J Oncol; 2016 Jul; 49(1):253-64. PubMed ID: 27211510
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mutational and structural analysis of diffuse large B-cell lymphoma using whole-genome sequencing.
    Morin RD; Mungall K; Pleasance E; Mungall AJ; Goya R; Huff RD; Scott DW; Ding J; Roth A; Chiu R; Corbett RD; Chan FC; Mendez-Lago M; Trinh DL; Bolger-Munro M; Taylor G; Hadj Khodabakhshi A; Ben-Neriah S; Pon J; Meissner B; Woolcock B; Farnoud N; Rogic S; Lim EL; Johnson NA; Shah S; Jones S; Steidl C; Holt R; Birol I; Moore R; Connors JM; Gascoyne RD; Marra MA
    Blood; 2013 Aug; 122(7):1256-65. PubMed ID: 23699601
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Genetic heterogeneity of diffuse large B-cell lymphoma.
    Zhang J; Grubor V; Love CL; Banerjee A; Richards KL; Mieczkowski PA; Dunphy C; Choi W; Au WY; Srivastava G; Lugar PL; Rizzieri DA; Lagoo AS; Bernal-Mizrachi L; Mann KP; Flowers C; Naresh K; Evens A; Gordon LI; Czader M; Gill JI; Hsi ED; Liu Q; Fan A; Walsh K; Jima D; Smith LL; Johnson AJ; Byrd JC; Luftig MA; Ni T; Zhu J; Chadburn A; Levy S; Dunson D; Dave SS
    Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1398-403. PubMed ID: 23292937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. AICDA drives epigenetic heterogeneity and accelerates germinal center-derived lymphomagenesis.
    Teater M; Dominguez PM; Redmond D; Chen Z; Ennishi D; Scott DW; Cimmino L; Ghione P; Chaudhuri J; Gascoyne RD; Aifantis I; Inghirami G; Elemento O; Melnick A; Shaknovich R
    Nat Commun; 2018 Jan; 9(1):222. PubMed ID: 29335468
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genetics of diffuse large B-cell lymphoma.
    Pasqualucci L; Dalla-Favera R
    Blood; 2018 May; 131(21):2307-2319. PubMed ID: 29666115
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated GLI3 expression in germinal center diffuse large B cell lymphoma.
    Han W; Ibarra G; Gupta M; Yin Y; Elsawa SF
    Leuk Lymphoma; 2018 Nov; 59(11):2743-2745. PubMed ID: 29465267
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.